Skip to main content

Restrictive Strategy for Gallstone Surgery Does Not Change Five-Year Outcomes

By Lori Solomon HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 29, 2024.

via HealthDay

THURSDAY, Aug. 29, 2024 -- In patients with abdominal pain and gallstones, a more restrictive approach may avoid unnecessary cholecystectomies, with no difference in five-year outcomes, according to a study published online Aug. 21 in JAMA Surgery.

Daan J. Comes, M.D., from Radboud University Medical Centre in Nijmegen, Netherlands, and colleagues evaluated the long-term impact of restrictive selection or usual care for cholecystectomy in patients with symptomatic cholelithiasis. Persistent pain and biliary and surgical complications were evaluated at five-year follow-up for 1,067 patients.

The researchers found that at follow-up, 62.8 percent of patients were pain-free in the usual care group versus 61.2 percent in the restrictive strategy group. Similar percentages were pain-free after cholecystectomy (63.6 percent in the usual care group versus 63.0 percent in the restrictive strategy group). The number of patients receiving cholecystectomies was lower with the restrictive care strategy (73.2 percent) versus usual care (81.5 percent). There were no differences between the groups for biliary and surgical complications or for patient satisfaction.

"Regardless of the strategy, only two-thirds of patients were pain-free," the authors write. "Further criteria for selecting patients with uncomplicated cholelithiasis for cholecystectomy and rethinking laparoscopic cholecystectomy as treatment is needed to improve patient-reported outcomes."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Presurgical Immunotherapy Offers Long-Term Benefit in Melanoma

FRIDAY, July 18, 2025 -- Neoadjuvant systemic treatment (NST) followed by adjuvant treatment with nivolumab and relatlimab offers long-term benefit in adults with stage III/IV...

Velar Adhesion Reduces Cleft Width Prior to Palatoplasty in Cleft Lip

TUESDAY, July 15, 2025 -- For patients with unilateral cleft lip and palate (UCLP), velar adhesion (VA) reduces cleft width prior to palatoplasty and is associated with a lower...

Wearable-Derived Biorhythms Predict Complications After Appendectomy

MONDAY, July 14, 2025 -- Wearable-derived biorhythms can predict postoperative complications in children undergoing appendectomy, according to a study published online July 9 in...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.